Gene: SLC22A3 ×
Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9364554
rs9364554
SLC22A3
T 0.710 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018
dbSNP: rs9364554
rs9364554
SLC22A3
T 0.710 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015
dbSNP: rs9364554
rs9364554
SLC22A3
0.710 GeneticVariation BEFREE Three of the 23 genetic variants explored were nominally associated with prostate cancer progression; rs9364554 (P = 0.041) on chromosome 6q25 and rs10896449 (P = 0.029) on chromosome 11q13 among patients treated with curative intent; and rs4054823 (P = 0.008) on chromosome 17p12 among patients on surveillance. 21520160

2012
dbSNP: rs9364554
rs9364554
SLC22A3
T 0.710 GeneticVariation GWASCAT Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008
dbSNP: rs3123636
rs3123636
SLC22A3
C 0.700 GeneticVariation GWASCAT Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. 27262462

2016
dbSNP: rs7758229
rs7758229
SLC22A3
T 0.700 GeneticVariation GWASCAT Two susceptibility loci identified for prostate cancer aggressiveness. 25939597

2015